Skip to main content
OpenTrials
Completed

NCT Number: NCT03320161

A Patient Consensus for the Research in Supportive Care in French Cancer Care Centers: the CyPRES Project

In oncology a number of supportive care therapies are proposed to patients. This study will identify the different therapies and prioritize these therapies from the patients' perspectives. This study will provide a framework for optimizing supportive care strategies and identifying those therapies that need to be validated by clinical trials.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ligue Nationale Contre le Cancer - Comité de la Somme, Amiens, France

Loading trial locations.

About this study

In oncology, supportive care should be used along with curative treatment or palliative care in order to improve patients' health-related quality of life, overall survival and to better support treatment side effects as well as the disease evolution. Unfortunately, they are not widely used in clinical practice.

A direct assessment of the needs perceived unmet by patients could allow to assess the magnitude of expectations to better target treatments as example. A prospective assessment of the expectations and needs of the patients is thus essential. This would also allow help to highlight the convergence between supportive care proposed and used and those expected by patients. The first step to understanding how to optimize the use of resources and to improve the quality of care is to identify patient's expectations. Moreover, it is now well recognized that patients should play a key role in the research and that their active participation in research can increase the relevance of the research.

In this context, the CyPRES project aims to:

  • assess through national consensus the patients' expectations in terms of supportive care in order to help both clinicians and health care services;
  • prioritize them and to arrange resources according to priority needs identified;
  • identify supportive care for which no previous research (evidence-based medicine) has demonstrated their usefulness. A randomized clinical trial will thus be proposed;
  • Involve patients in the written, conduct and analyses, as well as communications of the randomized clinical trial.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients supported for cancer
  • patients of ERI, Espaces Ligue (french cancer care centers) or patient associations
  • patients aged at least 18 years old

Exclusion criteria

  • Not applicable

Treatment and study plan

Primary outcomes

  1. Supportive care listed and prioritized by patients

    Time frame: At inclusion visit

    Expectations and needs of the patients: completion of questionnaire N°1

  2. Supportive care listed and prioritized by patients

    Time frame: 4 to 7 months after inclusion

    Prioritize supportive care therapies: completion of questionnaire N°2 Expectations and needs of the patients questionnaire n°2 completed

Sponsors and collaborators

Lead sponsor

UNICANCER

Other

Collaborators

  • Association Francophone des Soins Oncologiques de Support
  • French National Platform Quality of Life and Cancer
  • Ligue contre le cancer, France

Registry information

Acronym: CyPRES

Important dates

Study start
2018
Primary completion
2019
Study completion
2021
First posted
Oct 25, 2017
Registry last updated
Nov 4, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.